Predicted basal metabolic rate and cancer risk in the European Prospective Investigation into Cancer and Nutrition

Summary, in English

Emerging evidence suggests that a metabolic profile associated with obesity may be a more relevant risk factor for some cancers than adiposity per se. Basal metabolic rate (BMR) is an indicator of overall body metabolism and may be a proxy for the impact of a specific metabolic profile on cancer risk. Therefore, we investigated the association of predicted BMR with incidence of 13 obesity-related cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). BMR at baseline was calculated using the WHO/FAO/UNU equations and the relationships between BMR and cancer risk were investigated using multivariable Cox proportional hazards regression models. A total of 141,295 men and 317,613 women, with a mean follow-up of 14 years were included in the analysis. Overall, higher BMR was associated with a greater risk for most cancers that have been linked with obesity. However, among normal weight participants, higher BMR was associated with elevated risks of esophageal adenocarcinoma (hazard ratio per 1-standard deviation change in BMR [HR_1-SD]: 2.46; 95% CI 1.20; 5.03) and distal colon cancer (HR_1-SD: 1.33; 95% CI 1.001; 1.77) among men and with proximal colon (HR_1-SD: 1.16; 95% CI 1.01; 1.35), pancreatic (HR_1-SD: 1.37; 95% CI 1.13; 1.66), thyroid (HR_1-SD: 1.65; 95% CI 1.33; 2.05), postmenopausal breast (HR_1-SD: 1.17; 95% CI 1.11; 1.22) and endometrial (HR_1-SD: 1.20; 95% CI 1.03; 1.40) cancers in women. These results indicate that higher BMR may be an indicator of a metabolic phenotype associated with risk of certain cancer types, and may be a useful predictor of cancer risk independent of body fatness.